Yahoo Web Search

Search results

    • Q1 2024 Gilead Sciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 11 hours ago

      If approved, we will leverage our industry-leading commercial infrastructure and long-standing expertise in liver disease to bring seladelpar a potentially transformative therapy to